A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes

Published:2020-04-15 Issue:4 Volume:25 Page:655-670
ISSN:0949-8257
Container-title:JBIC Journal of Biological Inorganic Chemistry
language:en
Short-container-title:J Biol Inorg Chem

Author:

Corinti Davide^ORCID,Crestoni Maria Elisa^ORCID,Fornarini Simonetta^ORCID,Dabbish Eslam,Sicilia Emilia,Gabano Elisabetta^ORCID,Perin Elena^ORCID,Osella Domenico^ORCID

Funder

EU Framework Programme for Research and Innovations HORIZON 2020

Università della Calabria

Sapienza Università di Roma

Università degli Studi del Piemonte Orientale

Publisher

Springer Science and Business Media LLC

Subject

Inorganic Chemistry,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s00775-020-01789-w.pdf

Reference74 articles.

1. Graf N, Lippard SJ (2012) Redox activation of metal-based prodrugs as a strategy for drug delivery. Adv Drug Deliv Rev 64(11):993–1004. https://doi.org/10.1016/j.addr.2012.01.007

2. Wexselblatt E, Gibson D (2012) What do we know about the reduction of Pt(IV) pro-drugs? J Inorg Biochem 117:220–229. https://doi.org/10.1016/j.jinorgbio.2012.06.013

3. Nemirovski A, Vinograd I, Takrouri K, Mijovilovich A, Rompel A, Gibson D (2010) New reduction pathways for ctc-PtCl2(CH3CO2)2(NH3)(Am) anticancer prodrugs. Chem Commun 46(11):1842–1844. https://doi.org/10.1039/b925721g

4. Ravera M, Gabano E, Zanellato I, Bonarrigo I, Escribano E, Moreno V, Font-Bardia M, Calvet T, Osella D (2012) Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin. Dalton Trans 41(11):3313–3320. https://doi.org/10.1039/c2dt11874b

5. Hall MD, Hambley TW (2002) Platinum(IV) antitumour compounds: their bioinorganic chemistry. Coord Chem Rev 232(1–2):49–67. https://doi.org/10.1016/s0010-8545(02)00026-7

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning-Based Prediction of Reduction Potentials for Pt^IV Complexes;Journal of Chemical Information and Modeling;2024-04-29

2. Investigation of Siderophore–Platinum(IV) Conjugates Reveals Differing Antibacterial Activity and DNA Damage Depending on the Platinum Cargo;ACS Infectious Diseases;2024-03-04

3. Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands;Coordination Chemistry Reviews;2024-02

4. Advances in technical strategies for monitoring the reduction of platinum(iv) complexes;Inorganic Chemistry Frontiers;2024

5. Pt(iv) anticancer prodrugs bearing an oxaliplatin scaffold: what do we know about their bioactivity?;Inorganic Chemistry Frontiers;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3